SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+20.28%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$302M
AUM Growth
+$302M
(+19%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
7.88%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
62
New
24
Increased
12
Reduced
14
Closed
11
Top Buys
| 1 |
Quest Diagnostics
DGX
|
$14.2M |
| 2 |
Labcorp
LH
|
$9.97M |
| 3 |
Hologic
HOLX
|
$5.7M |
| 4 |
Medtronic
MDT
|
$5.5M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
$5.23M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$16.5M |
| 2 |
UnitedHealth
UNH
|
$10.6M |
| 3 |
Encompass Health
EHC
|
$7.73M |
| 4 |
Universal Health Services
UHS
|
$6.54M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$6.02M |
Sector Composition
| 1 | Healthcare | 95.1% |
| 2 | Energy | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
26
DELISTED
LHC Group LLC
LHCG
| $5.23M | 1.73% |
+30,000
| New | +$5.23M |
|
|
AMED
27
DELISTED
Amedisys
AMED
| $4.96M | 1.64% |
+25,000
| New | +$4.96M |
|
|
NVRO
28
DELISTED
NEVRO CORP.
NVRO
| $4.78M | 1.58% |
+40,000
| New | +$4.78M |
|
29
Molina Healthcare
MOH
$9.6B
| $4.63M | 1.53% |
+26,000
| New | +$4.63M |
|
30
Zimmer Biomet
ZBH
$20.8B
| $4.36M | 1.44% |
25,750
+5,150
| +25% | +$872K |
|
31
Becton Dickinson
BDX
$54.3B
| $4.25M | 1.41% |
+18,206
| New | +$4.25M |
|
32
Johnson & Johnson
JNJ
$429B
| $4.22M | 1.4% |
+30,000
| New | +$4.22M |
|
33
Thermo Fisher Scientific
TMO
$183B
| $4.04M | 1.34% |
106,069
+6,069
| +6% | +$231K |
|
|
PPD
34
DELISTED
PPD, Inc. Common Stock
PPD
| $4.02M | 1.33% |
+150,000
| New | +$4.02M |
|
35
Biogen
BIIB
$20.5B
| $4.01M | 1.33% |
15,000
-5,000
| -25% | -$1.34M |
|
36
Gilead Sciences
GILD
$140B
| $3.85M | 1.27% |
+50,000
| New | +$3.85M |
|
37
Tenet Healthcare
THC
$16.5B
| $3.84M | 1.27% |
25,000
+7,500
| +43% | +$1.15M |
|
|
38
Bristol-Myers Squibb
BMY
$96.7B
| $3.81M | 1.26% |
60,000
-260,000
| -81% | -$16.5M |
|
39
Illumina
ILMN
$15.2B
| $3.7M | 1.23% |
+10,280
| New | +$3.7M |
|
40
Teva Pharmaceuticals
TEVA
$21.5B
| $3.39M | 1.12% |
+275,000
| New | +$3.39M |
|
41
Avantor
AVTR
$8.74B
| $2.98M | 0.99% |
+175,000
| New | +$2.98M |
|
42
Amneal Pharmaceuticals
AMRX
$3B
| $2.86M | 0.95% |
+600,000
| New | +$2.86M |
|
43
BioNTech
BNTX
$24.1B
| $2.67M | 0.88% |
+40,000
| New | +$2.67M |
|
44
Adaptive Biotechnologies
ADPT
$1.96B
| $2.42M | 0.8% |
+50,000
| New | +$2.42M |
|
45
Owens & Minor
OMI
$423M
| $2.28M | 0.75% |
+298,700
| New | +$2.28M |
|
46
CRISPR Therapeutics
CRSP
$4.82B
| $2.21M | 0.73% |
+30,000
| New | +$2.21M |
|
47
Agios Pharmaceuticals
AGIO
$2.36B
| $2.14M | 0.71% |
+40,000
| New | +$2.14M |
|
|
BLUE
48
DELISTED
bluebird bio
BLUE
| $2.14M | 0.71% |
+2,702
| New | +$2.14M |
|
49
Abbott
ABT
$230B
| $1.93M | 0.64% |
25,000
-40,000
| -62% | -$3.09M |
|
|
CNST
50
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.8M | 0.6% |
+60,000
| New | +$1.8M |
|